The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
FDA approves Enbrel to treat psoriasis

THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., April 30, 2004 Amgen (N), today announced that Enbrel® (etanercept) has been approved by the U.S. Food and Drug Ad ASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYEministration (FDA) for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The psoriasis indication marks the fifth disease for which ENBREL has received an FDA approval in just over five years.

Psoriasis is a chronic immune disorder in which certain immune cells become overactive and release proteins called cytokines. Tumor necrosis faction (TNF) is one of those cytokines that helps regulate the body's immune response to infection and inflammation. In patients with psoriasis, TNF causes inflammation, which can lead to the formation of painful, often disfiguring psoriasis plaques. As an anti-TNF therapy, ENBREL binds to the over-produced TNF and renders it biologically inactive, which can result in a significant reduction in inflammation.

"Both physicians and patients have expressed a desire for new options to treat psoriasis. ENBREL rapidly cleared psoriasis in many patients and was generally well tolerated in two large clinical trials," said Laura Hamill, vice president and general manager of Amgen's Inflammation Business Unit. "This approval in psoriasis, coupled with our previous indication in psoriatic arthritis, reinforces our commitment to dermatology and our core aspiration of providing treatments that can dramatically improve people's lives."

The approval was based on data from two Phase 3 studies totaling more than 1,200 adults with plaque psoriasis who were treated with ENBREL for up to 12 months. ENBREL was approved with a step-down dosing regimen of 50 mg administered twice-weekly for three months, followed by a maintenance dose of 50 mg weekly thereafter. ENBREL demonstrated rapid and
'"/>


2-May-2004


Page: 1 2 3 4 5

Related medicine news :

1. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
2. FDA approves Enablex for treatment of overactive bladder
3. FDA approves Fosrenol(R) in end-stage renal disease (ESRD) patients
4. FDA approves Adderall XR (R) to treat ADHD in adults
5. FDA approves EPZICOM
6. FDA approves new labelling for Seroquel in bioplar mania
7. FDA approves Climara Pro to treat menopause symptoms
8. FDA approves new approach to schizophrenia treatment
9. FDA approves new HIV protease inhibitor, Lexiva (TM)
10. FDA approves Wellbutrin XL(TM)
11. FDA approves Baxters ADVATE for the treatment of hemophilia A

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA approves Enbrel treat psoriasis

(Date:11/21/2009)...ovisions of Legislation, Continues Push for Progre... Nov. 21 With the U.S...fordable Health Care for America Act (H.R. 3962), ...n forward, Congress has taken decisive steps to fi...AARP hosted an educational forum to discuss the pr...
(Date:11/21/2009)...l credentialing software company IntelliSoft Group...p with Amerinet, Inc., the leading healthcare G.P....sform quality care within the healthcare market. ...9 -- ISG Group, LLC, doing business as IntelliSoft...t Inc., a leading national healthcare group purcha...
(Date:11/21/2009)...ost popular and addictive game, SplitWords, is now... Mountain View, CA (PRWEB) Novemb...ctive game, SplitWords, is now available on the iP...lp banish that ,tip of the tongue, syndrome foreve...ges the brain by encouraging users to form complet...
(Date:11/21/2009)...l Group merges their practice with that of E. Stev... (PRWEB) November 21, 2009 -- The New H... Gibson, Dr. Dean Cloutier, Dr. John Plachtyna and...g practice with that of esteemed colleague Dr. E. ...nted to retire from dentistry in order to concentr...
(Date:11/20/2009)...to Understanding Brain Wiring and Diseases ,, W...Jeremy Schmahmann, Professor of Neurology at Harva...etts General Hospital in Boston, on Thursday, Nove...e new field of study called "Connectivity" at the ...hmann is an award-winning leader in the field of t...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:New Haven Dental Group Expands Their Vision 2Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
(Date:11/20/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue. ,, Global Markets for Assisted Reproductiv...m/p0164742/Global-Markets-for-Assisted-Reproductiv...medium=pr&utm_campaign=prnewswire ,, Glob...S., 15 Countries in Europe and Japan. This report ...
(Date:11/20/2009)...ov. 20 In response to a...y currently available medications designed to trea... Institute, an independent nonprofit organization,...ride for Prevention of Prostate Cancer for free ...Times article, " Drugs to Deter Some Cancers Are ...
(Date:11/19/2009)... BioCryst Pharmaceutical...ng of a public offering of 5,000,000 shares of its...ss proceeds of $48.75 million. All of the shares ...tive shelf registration statement previously filed...Cryst has also granted the underwriters a 30-day o...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Drake Center is Site for 243 6 Million NIH Grant to Study Mental Rehearsal that Improves Motor Skills in Stroke Patients 60443 1Drake Center is Site for 243 6 Million NIH Grant to Study Mental Rehearsal that Improves Motor Skills in Stroke Patients 60443 2Drake Center is Site for 243 6 Million NIH Grant to Study Mental Rehearsal that Improves Motor Skills in Stroke Patients 60443 3OMG Announces Special Event 3A Terminology Services Information Day 60441 1OMG Announces Special Event 3A Terminology Services Information Day 60441 2OMG Announces Special Event 3A Terminology Services Information Day 60441 3Community Blood Drives Benefit Cancer Patients 60439 1Community Blood Drives Benefit Cancer Patients 60439 2
Other News:
...sal requiring all Americans to buy health insuranc...would replace employer-sponsored health insurance ...interview published today on the Health Affairs We... a former Medicare chief and the John M. Olin seni...
...- A good way to learn whether children under 6 yea...cording to a team of infant and preschool investig...in St. Louis.......Reporting in the March issue of...Adolescent Psychiatry, the researchers say that pr...
...To celebrate the Journe Qubcoise des allergies ali...bcoise des allergies alimentaires (AQAA) and the M...day results from the first Quebec study on the pre...ge of the occasion to launch an ambitious program ...
..., 2003 Advanced materials look set to revolutioni...ntists and engineers are undertaking extensive res...icated new materials that are more durable, enviro...dvanced materials and chemicals are the enabling b...
health news:In Health Affairs interview, Breaux outlines plan to cover uninsured 2health news:Identifying depression in preschoolers 2health news:Identifying depression in preschoolers 3health news:Two major food allergy firsts in North America 2health news:For markets of the future, success depends on advanced materials 2
... much as neuroscientists know about the neural pro...nderstood about the neural correlates of conscious...in the open-access journal PLoS Biology, Felix Bla... a classic somatosensory illusion--called the cuta...
...mbining aggressive HIV therapy and chemotherapy si...itive men and women treated for lymphoma, accordin...ssue of CANCER (http://www.interscience.wiley.com/...merican Cancer Society, the study reveals that com...
...EVELAND A growing population of chronically criti... all hospital intensive care unit (ICU) resources ... turn, health care providers pass those costs onto...erve University's Frances Payne Bolton School of N...
...ientists have completed an extensive study of more...-inflammatory drug, natalizumab, that was linked t...e clinical trials halted in early 2005.......The n...cal leukoencephalopathy (PML) and confirmed the th...
health news:Classic illusion sheds new light on the neural site of tactile perception 2health news:Combination therapy improves AIDS-related lymphoma outcome 2health news:Better communication between families, health care providers can reduce cost, length of stay in ICU 2health news:Better communication between families, health care providers can reduce cost, length of stay in ICU 3health news:Anti-inflammatory drug's potentially deadly side effect found to be rare 2health news:Anti-inflammatory drug's potentially deadly side effect found to be rare 3health news:Anti-inflammatory drug's potentially deadly side effect found to be rare 4